Latest News
3 Reasons Why Walgreens Boots Alliance Stock May Not Be Doomed
Walgreens stock has been a falling knife this year, but the company has levers it can pull on to strengthen its operations.
Why Realty Income Might Be 1 of the Best Dividend Stocks You Can Own
There's more to this stock than just its high payout.
2 Magnificent S&P 500 Dividend Stocks Down 20% or More to Buy and Hold Forever
These stocks are well off the highs and could be big winners in 2025 and beyond.
Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?
Dividend stocks could get more attention as interest rates fall.
Where Will Walgreens Boots Alliance Be in 3 Years?
It could be smaller, but more financially sustainable if things go as planned.
Is Walgreens Boots Alliance Stock a Buy?
Its challenges are formidable, so only certain investors should consider it.
Why I Just Bought These 2 High-Yield REIT Stocks
These REIT stocks offer more than just juicy dividend yields.
Looking for Stock Bargains With Room to Run? Try This.
Investing tips from Bill Mann, The Motley Fool's director of small-cap research.
1 Healthcare Stock to Sell Now and Never Look Back
This company probably won't go bankrupt, but the stock is unlikely to go up.
3 Stocks That Cut You a Check Each Month
It's absolutely possible to collect investment income at the same rate you're most likely to need it.
Realty Income: The Bad News Isn't as Bad as It Seems. 3 Things Investors Should Know.
Investors worry that Realty Income has some troubled tenants, but it's not as big a deal as it may appear.
4 REIT Stocks That Are Screaming Buys in September
Realty Income, Vici, STAG, and Digital Realty are all solid REIT plays.
/Walgreens%20Boots%20Alliance%20Inc%20store-%20by%20Sundry%20Photography%20via%20Shutterstock.jpg)
Walgreens stock is trading below $10, and near its lowest price since 1996. Why is WBA's stock price so low, and is the pharma chain a buy for its over 11% dividend yield?
Nutriband (NASDAQ: NTRB) Releases Q2 Report, AVERSA Fentanyl Update
Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, is reporting its Q2 2024 financial results for the period ending July 31, 2024. According to the report, the company ended the quarter in a strong cash position,...
2 Dividend Stocks With Payouts That May Not Be as Safe as They Seem
Johnson & Johnson and Altria Group are two prominent dividend stocks, but I wouldn't rely on their payouts.
Why Walgreens Boots Alliance Fell Another 22% in August
The retail pharmacy giant faces ever-mounting headwinds.
Down About 65% in 2024, Is Walgreens Stock a Buy on the Dip?
Shares of the dividend-paying pharmacy chain have been offering a double-digit yield percentage.
A $14 Trillion Passive Income Investment Opportunity Is Hiding in Plain Sight (and It's Easier to Access Than You Think)
Freestanding commercial real estate is a goldmine of passive income.
Should You Buy the 3 Highest-Yielding Dividend Stocks in the S&P 500?
Walgreens, Altria, and Verizon all have high yields, but are they worth buying just for the yield? Probably not. Here's a deeper look at each.
2 Reasons to Buy This 5%-Yielding REIT Hand Over Fist Right Now
Realty Income stock looks like a bargain right now.
Intel Suspended Its Dividend, and This Stock Could Be the Next One to Halt Its High-Yielding Payout
Is it only a matter of time before Walgreens Boots Alliance suspends its dividend as well?
Why Walgreens Boots Alliance Plunged Today
Major drug companies are increasingly going direct-to-consumer.
3 Struggling Stocks That Aren't Worth Buying on the Dip
These stocks are all down more than 30% in just three months.
Walgreens Is Reportedly Considering a Drastic Move to Improve Its Cash Flow
Will Walgreens dump its stake in VillageMD?
/Intel%20Corp_%20Santa%20Clara%20campus-by%20jejim%20via%20Shutterstock.jpg)
Intel stock fell to a decade low earlier this month after disastrous Q2 earnings. What's the 2025 forecast for Intel, and can the company recover from its lows?